HK1041607A1 - 製備n6-取代的脫氮雜-腺苷衍生物的方法 - Google Patents

製備n6-取代的脫氮雜-腺苷衍生物的方法

Info

Publication number
HK1041607A1
HK1041607A1 HK02103284.7A HK02103284A HK1041607A1 HK 1041607 A1 HK1041607 A1 HK 1041607A1 HK 02103284 A HK02103284 A HK 02103284A HK 1041607 A1 HK1041607 A1 HK 1041607A1
Authority
HK
Hong Kong
Prior art keywords
preparing
adenosine derivatives
deaza
substituted
substituted deaza
Prior art date
Application number
HK02103284.7A
Other languages
English (en)
Inventor
D‧C‧薩拉扎
W‧羅德裡桂茲
J‧P‧舍爾賓
R‧G‧伍德沃德
A‧W‧斯萊迪斯基
M‧R‧鮑沃斯
M‧K‧歐布裡恩
Original Assignee
阿溫蒂斯藥物製品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿溫蒂斯藥物製品公司 filed Critical 阿溫蒂斯藥物製品公司
Publication of HK1041607A1 publication Critical patent/HK1041607A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02103284.7A 1998-12-21 2002-05-02 製備n6-取代的脫氮雜-腺苷衍生物的方法 HK1041607A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21
PCT/US1999/029643 WO2000037469A2 (en) 1998-12-21 1999-12-14 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
HK1041607A1 true HK1041607A1 (zh) 2002-07-12

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103284.7A HK1041607A1 (zh) 1998-12-21 2002-05-02 製備n6-取代的脫氮雜-腺苷衍生物的方法

Country Status (28)

Country Link
US (1) US6184382B1 (zh)
EP (1) EP1175420B1 (zh)
JP (1) JP2002533343A (zh)
KR (1) KR20010087425A (zh)
CN (1) CN1122667C (zh)
AP (1) AP1336A (zh)
AT (1) ATE235493T1 (zh)
AU (1) AU774155B2 (zh)
BG (1) BG105624A (zh)
BR (1) BR9917088A (zh)
CA (1) CA2357760A1 (zh)
CZ (1) CZ20012283A3 (zh)
DE (1) DE69906392T2 (zh)
DK (1) DK1175420T3 (zh)
EA (1) EA003645B1 (zh)
EE (1) EE200100333A (zh)
ES (1) ES2191489T3 (zh)
HK (1) HK1041607A1 (zh)
HU (1) HUP0105224A3 (zh)
ID (1) ID30118A (zh)
IL (1) IL143843A0 (zh)
NO (1) NO319789B1 (zh)
NZ (1) NZ512500A (zh)
PL (1) PL349154A1 (zh)
PT (1) PT1175420E (zh)
SK (1) SK284767B6 (zh)
WO (1) WO2000037469A2 (zh)
YU (1) YU51401A (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9713705A (pt) * 1996-12-11 2000-05-09 Rhone Poulenc Rorer Pharma Composto, e, processo para a preparação do mesmo
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
WO1992005177A1 (en) * 1990-09-25 1992-04-02 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties

Also Published As

Publication number Publication date
AP1336A (en) 2004-11-30
SK9072001A3 (en) 2001-12-03
IL143843A0 (en) 2002-04-21
WO2000037469A2 (en) 2000-06-29
AU774155B2 (en) 2004-06-17
NO20013044L (no) 2001-08-20
DE69906392D1 (de) 2003-04-30
HUP0105224A3 (en) 2003-01-28
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
PT1175420E (pt) 2003-08-29
EE200100333A (et) 2002-08-15
AP2001002200A0 (en) 2001-09-30
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
EA200100697A1 (ru) 2001-12-24
NO319789B1 (no) 2005-09-12
CZ20012283A3 (cs) 2001-10-17
EP1175420A2 (en) 2002-01-30
ES2191489T3 (es) 2003-09-01
BG105624A (en) 2002-01-31
NO20013044D0 (no) 2001-06-19
WO2000037469B1 (en) 2000-11-02
PL349154A1 (en) 2002-07-01
CN1122667C (zh) 2003-10-01
ID30118A (id) 2001-11-08
NZ512500A (en) 2003-01-31
DE69906392T2 (de) 2004-02-05
EA003645B1 (ru) 2003-08-28
CN1333773A (zh) 2002-01-30
BR9917088A (pt) 2006-01-31
HUP0105224A2 (en) 2002-06-29
AU2181400A (en) 2000-07-12
US6184382B1 (en) 2001-02-06
KR20010087425A (ko) 2001-09-15
WO2000037469A3 (en) 2000-09-14
YU51401A (sh) 2003-12-31
JP2002533343A (ja) 2002-10-08
EP1175420B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
HUP0203206A3 (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
AU3994299A (en) Process for preparing 4-aminodiphenylamines
HU9800615D0 (en) Process for producing bis-hydroxy-methyl derivatives
IL137828A0 (en) Process for preparing protected 4-aminomethyl-pyrrolidin-3-one
EP1019359A4 (en) TECHNIQUE FOR THE PREPARATION OF AMINOARYLACETYLENES
EG23935A (en) Process for preparing eprosartin
EG22077A (en) Process for preparing 4-substituted-ih-indole-3 glyoxamides
EP1089978A4 (en) METHOD FOR PRODUCING OXIMIDAZOLES
EG22139A (en) Process for preparing 4- substituted-1H-indole -3- glyoxamides
PL349154A1 (en) Process for preparing n6-substituted deaza-adenosine derivatives
IL126184A (en) Process for preparing pentafluoropentanol
EP1055732A4 (en) METHOD FOR PRODUCING A (R) -2-HYDROXY-1-PHENOXYPROPANDERIVAT
HUP0000559A3 (en) Process for preparing cyanoaceticacidesters
HUP9904315A3 (en) Process for preparing orthoesters
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
HUP9802646A3 (en) Process for producing formylimidazol derivatives
EG21526A (en) Improved process for preparing pharmaceutically useful norbenzomorphane derivatives
IL143239A0 (en) Process for preparing pyridazin-3-on derivatives
HUP0000208A3 (en) Process for producing secondary-alkoxy-1-alkene derivatives
HUP9800372A3 (en) Process for producing trans-phenyl-glycidyl-acid derivatives
IL143306A0 (en) Process for preparing trichloroalkane derivatives
EP1119549A4 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-1H-INDOLE-3-GLYOXAMIDES
IL125646A0 (en) Process for preparing n-pyruvyl-l-proline
GB9825422D0 (en) Process for preparing pollyketones